Koers Seach Medical Group Ltd TEL AVIV STOCK EXCHANGE
Aandelen
SEMG
IL0002490113
Drugshandelaren
Omzet 2022 | 134 mln. 35,28 mln. 32,9 mln. | Omzet 2023 | 150 mln. 39,52 mln. 36,86 mln. | Marktkapitalisatie | 59,61 mln. 15,67 mln. 14,61 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -3 mln. -789K -736K | Nettowinst (verlies) 2023 | -10 mln. -2,63 mln. -2,45 mln. | EV/omzet 2022 | 0,51 x |
Nettoschuld 2022 | 6,41 mln. 1,69 mln. 1,57 mln. | Nettoschuld 2023 | 12,61 mln. 3,31 mln. 3,09 mln. | EV/omzet 2023 | 0,48 x |
K/w-verhouding 2022 |
-18,2
x | K/w-verhouding 2023 |
-5,67
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 35,94% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yogev Sarid
CEO | Chief Executive Officer | 45 | 04-09-19 |
Amichay Rab
DFI | Director of Finance/CFO | 41 | 04-09-19 |
Chief Tech/Sci/R&D Officer | 52 | 04-09-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yaacov Amidror
BRD | Director/Board Member | 75 | 22-10-19 |
Nir Zichlinskey
CHM | Chairman | 58 | 22-10-19 |
Chief Tech/Sci/R&D Officer | 52 | 04-09-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,14% | 2,78 mld. | |
+9,01% | 1,61 mld. | |
+81,18% | 613 mln. | |
-0,91% | 464 mln. | |
+30,99% | 162 mln. | |
+14,90% | 110 mln. | |
-2,77% | 101 mln. | |
+50,56% | 56,08 mln. |